A gonadotrophin-responsive virilizing adrenal tumour identified as a mixed ganglioneuroma and adreno-cortical adenoma.
D015065:17-Hydroxycorticosteroids / Q000652:urine; D015068:17-Ketosteroids / Q000652:urine; D000236:Adenoma / Q000378:metabolism / Q000473:pathology; D000302:Adrenal Cortex / Q000473:pathology; D000310:Adrenal Gland Neoplasms / Q000378:metabolism / Q000473:pathology; D000324:Adrenocorticotropic Hormone / Q000008:administration & dosage; D000328:Adult; D000735:Androstenedione / Q000097:blood; D006063:Chorionic Gonadotropin; D003687:Dehydroepiandrosterone / Q000097:blood; D003907:Dexamethasone; D005260:Female; D005640:Follicle Stimulating Hormone / Q000097:blood; D005729:Ganglioneuroma / Q000378:metabolism / Q000473:pathology; D007987:Gonadotropin-Releasing Hormone; D006801:Humans; D006854:Hydrocortisone / Q000097:blood; D007986:Luteinizing Hormone / Q000097:blood; D013739:Testosterone / Q000097:blood / Q000378:metabolism
D015065:17-Hydroxycorticosteroids; D015068:17-Ketosteroids; D006063:Chorionic Gonadotropin; D007987:Gonadotropin-Releasing Hormone; D013739:Testosterone; D000735:Androstenedione; D003687:Dehydroepiandrosterone; D003907:Dexamethasone; D000324:Adrenocorticotropic Hormone; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone; D006854:Hydrocortisone